RGPX Regenerex Pharma, Inc.

Fundamentals / CIK 0001357878 / USD

Regenerex Pharma, Inc. reported $618K in total assets and a net loss of $3.20M through March 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RGPX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2014 to 2025), reported in USD.

$1.22M$611K$0-$3.39MFY 2014 Net Income: $860K2014FY 2017 Net Income: -$2.6K2017FY 2018 Net Income: -$50K2018FY 2019 Net Income: -$94K2019FY 2020 Revenue: $2.6KFY 2020 Net Income: $112K2020FY 2021 Revenue: $1.8KFY 2021 Net Income: -$354K2021FY 2022 Net Income: -$196K2022FY 2023 Net Income: -$137K2023FY 2024 Net Income: -$3.54M2024FY 2025 Net Income: -$2.53M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Nov 30
Revenue -- -- -- -- $1.8K $2.6K -- -- -- --
Cost of Revenue -- -- -- -- $247K $1.7K -- -- -- --
Gross Profit -- -- -- -- -$245K $896 -- -- -- --
Research & Development $662K $2.40M -- -- -- -- -- -- -- --
Selling, General & Admin $1.16M $1.07M -- -- $52K $78K -- -- -- --
Total Operating Expenses $1.83M $3.47M $96K $126K $43K $78K $92K $49K $2.6K $25K
Operating Income -$1.83M -$3.47M -$96K -$126K -$43K -$77K -$92K -$49K -$2.6K --
EBITDA -$1.82M -$3.46M -$90K -$119K -$34K -$63K -$81K -$44K -- --
Interest Expense $320K $81K $67K $59K $43K $29K $778 -- -- $3.6K
Income Before Tax -- -- -- -- -- -- -- -- -- -$468K
Income Tax Expense -$2.7K -- -- -- -- -- -- -- -- --
Net Income -$2.53M -$3.54M -$137K -$196K -$354K $112K -$94K -$50K -$2.6K $860K
Basic Shares Outstanding 278.7M 277.7M 277.1M 183.4M 127.1M 127.1M 127.1M 137.7M 156.1M --
Diluted Shares Outstanding -- -- -- 183.4M 127.1M 127.1M 127.1M 137.7M 156.1M --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Research & Development $136K -- -- $17K -- -- -- --
Total Operating Expenses $787K $634K $1.00M $312K $258K $254K $280K $239K
Operating Income -$787K -$634K -$1.00M -$312K -$258K -$254K -$280K -$239K
EBITDA -$786K -$633K -$1.00M -$311K -$257K -$252K -$278K -$238K
Interest Expense $23K $24K $4.5K $27K $266K $22K $22K $20K
Income Tax Expense -$50 -$113 -- -- -- -- -- --
Net Income -$814K -$664K -$1.41M -$315K -$530K -$273K -$293K -$264K
Basic Shares Outstanding 281.5M 281.1M -- 278.4M 278.3M 278.2M -- 277.9M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 21 Mar 31 Mar 31 Mar 31 Nov 30
Cash & Cash Equivalents $653K $372 $1.1K $2.6K $6.9K $6.9K $5.5K $89K $1.7K $1.3K
Cash & Short-Term Investments $653K $372 $1.1K $2.6K $6.9K $6.9K $5.5K $89K $1.7K $1.3K
Inventory -- -- -- -- -- -- $247K -- -- --
Total Current Assets $653K $2.9K $1.1K $7.9K $8.1K $8.1K $252K $98K $1.7K --
Property, Plant & Equipment, Net -- $6.1K -- -- -- -- -- -- -- --
Intangible Assets $5.6K $1.3K $4.2K $7.4K $2.4K $2.4K $7.0K $8.0K $13K $2.5K
Other Non-Current Assets -- -- -- -- -- -- -- -- -- $2.5K
Total Non-Current Assets $610K $764K $5.4K $7.4K $2.4K $2.4K $7.0K $8.0K $13K --
Total Assets $1.26M $767K $6.5K $15K $10K $10K $259K $106K $15K $3.8K
Accounts Payable $198K $117K $75K $63K $48K $48K $51K $38K $38K $37K
Total Current Liabilities $4.92M $3.84M $777K $660K $621K $621K $519K $405K $336K --
Long-Term Debt -- $184K -- -- -- -- -- -- -- --
Total Non-Current Liabilities $496K $985K $353K $340K $224K $224K $222K $70K $0 --
Total Liabilities $5.42M $4.83M $1.13M $1.00M $845K $845K $740K $475K $336K $799K
Total Debt (incl. Leases) $678K $994K -- -- -- -- -- -- -- --
Common Stock $281K $278K $277K $277K $127K $127K $127K $127K $127K $156K
Retained Earnings -$8.14M -$5.62M -$2.07M -$1.93M -$1.74M -$1.74M -$1.39M -$1.27M -$1.18M -$106K
Total Stockholders' Equity -$4.16M -$4.06M -$1.12M -$986K -$835K -$835K -$481K -$370K -$321K -$795K
Total Equity -$4.16M -$4.06M -$1.12M -$986K -$835K -$835K -$481K -$370K -$321K -$795K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Cash & Cash Equivalents $12K $172K $653K $338 $294 -- $372 $7.9K
Cash & Short-Term Investments $12K $172K $653K $338 $294 -- $372 $7.9K
Total Current Assets $48K $193K $653K $988 $1.8K $2.4K $2.9K $9.3K
Property, Plant & Equipment, Net -- -- -- -- $5.2K -- $6.1K --
Intangible Assets -- $4.3K $5.6K -- $208 $614 $1.3K $2.0K
Total Non-Current Assets $569K $571K $610K $646K $631K $727K $764K $843K
Total Assets $618K $763K $1.26M $647K $633K $729K $767K $852K
Accounts Payable $219K $171K $198K $185K $155K $161K $117K $79K
Total Current Liabilities $4.92M $4.85M $4.92M $5.16M $4.85M $4.41M $3.84M $3.56M
Long-Term Debt -- -- -- -- -- -- $184K --
Total Non-Current Liabilities $393K $459K $496K $541K $540K $629K $985K $1.17M
Total Liabilities $5.32M $5.31M $5.42M $5.70M $5.39M $5.04M $4.83M $4.73M
Total Debt (incl. Leases) $584K $627K $678K $718K $706K $803K $994K $876K
Common Stock $282K $281K $281K $278K $278K $278K $278K $278K
Retained Earnings -$9.62M -$8.81M -$8.14M -$6.73M -$6.42M -$5.89M -$5.62M -$5.32M
Total Stockholders' Equity -$4.70M -$4.55M -$4.16M -$5.05M -$4.76M -$4.31M -$4.06M -$3.88M
Total Equity -$4.70M -$4.55M -$4.16M -$5.05M -$4.76M -$4.31M -$4.06M -$3.88M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Nov 30
Net Income -$2.53M -$3.54M -$137K -$196K $354K $112K $94K $50K $2.6K $860K
Depreciation & Amortization $4.4K $7.2K $6.6K $7.1K $9.3K $14K $11K $5.3K -- --
Stock-Based Compensation $133K $212K -- $45K -- -- $45K $10K -- --
Change in Inventory -- -- -- -- -$1.1K $247K -- -- -- --
Change in Payables $188K $160K $44K -- -- -- -- -- -- --
Operating Cash Flow -$1.63M -$458K -$76K -$70K -$63K -$291K $47K $36K $2.6K -$72K
Investing Cash Flow -$1.2K -$6.3K -$1.4K -$8.6K -- -$6.0K -- -$16K -- --
Common Stock Issued -- -- -- -- -- -- -- -- -- $40K
Financing Cash Flow $2.28M $463K $76K $74K $64K $214K $134K $54K $2.6K $73K
Net Change in Cash $653K -$763 -$1.5K -$4.3K $1.4K -$83K $87K $1.7K -- $7.8K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Net Income -$814K -$664K -$1.41M -$315K -$530K -$273K -$293K -$264K
Depreciation & Amortization $1.2K $1.3K $426 $851 $1.2K $1.9K $1.9K $1.9K
Stock-Based Compensation $178K $257K $58K $18K $36K $21K $57K $21K
Change in Payables $47K -$26K $67K $51K $6.8K $63K $58K $9.1K
Operating Cash Flow -$519K -$478K -$1.28M -$159K -$127K -$55K -$64K -$100K
Investing Cash Flow -- -- -- -- -- -- $0 $0
Financing Cash Flow $398K -$2.7K $1.94M $159K $127K $55K $57K $102K
Net Change in Cash -$161K -$481K $653K $44 $294 -$372 -$7.5K $1.8K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Nov 30
Gross Margin -- -- -- -- -13798.1% 34.4% -- -- -- --
Operating Margin -- -- -- -- -2445.7% -2952.6% -- -- -- --
Net Profit Margin -- -- -- -- -19929.7% 4278.7% -- -- -- --
Return on Assets (ROA) -200.0% -462.2% -2100.2% -1276.5% -3378.7% 43.1% -88.6% -329.6% -- 22514.5%
Current Ratio 0.13x 0.00x 0.00x 0.01x 0.01x 0.49x 0.24x 0.01x -- --
Quick Ratio 0.13x 0.00x 0.00x 0.00x 0.01x 0.01x 0.22x 0.01x -- --
Revenue Growth (YoY) -- -- -- -- -31.9% -- -- -- -- --
Gross Profit Growth (YoY) -- -- -- -- -27434.5% -- -- -- -- --
Net Income Growth (YoY) -- -- -- -- -417.0% -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -718.8% +30.3% +1303.9% -- --
5Y Net Income / Share Growth -1132.8% -- -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Return on Assets (ROA) -518.4% -382.3% -200.0% -217.9% -214.7% -498.0% -462.2% -386.9%
Current Ratio 0.01x 0.04x 0.13x 0.00x 0.00x 0.00x 0.00x 0.00x
Quick Ratio 0.00x 0.04x 0.13x 0.00x 0.00x -- 0.00x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001357878) · from November 30, 2009 Data through September 30, 2025 · synced Nov 21, 2026, 05:18 UTC · Open in terminal